Development of Small Molecule Radiation Sensitizers
小分子放射增敏剂的开发
基本信息
- 批准号:8518497
- 负责人:
- 金额:$ 1.56万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2009
- 资助国家:美国
- 起止时间:2009-12-11 至 2014-11-30
- 项目状态:已结题
- 来源:
- 关键词:A549AcuteApoptosisBiochemicalBiological AssayBlood VesselsBolus InfusionCD34 geneCell ProliferationCell membraneColon CarcinomaCoupledDNA biosynthesisDataDevelopmentDiseaseDisulfidesDorsalEndothelial CellsEnzymesEpithelial CellsExhibitsGeneticGenetic ScreeningGoalsHumanInjection of therapeutic agentIonizing radiationLeadLewis Lung CarcinomaMalignant NeoplasmsMediatingModelingMolecularMolecular TargetMorphogenesisMusNeoplasm MetastasisNon-Small-Cell Lung CarcinomaOxidation-ReductionProteinsRadiationRadiation ToleranceRadiation therapyRadiation-Sensitizing AgentsResearchRiskScreening ResultSkinStructureSulfhydryl CompoundsTestingTherapeuticToxic effectTumor-Associated VasculatureXenograft Modelanalogangiogenesiscancer cellcell motilitychemical geneticsclinical efficacydensitydesigninhibitor/antagonistirradiationmatrigelmigrationneoplastic cellnovelpublic health relevancescaffoldsmall hairpin RNAsmall moleculesmall molecule librariestumortumor growth
项目摘要
DESCRIPTION (provided by applicant):
We synthesized a novel synthetic chemical library and used it in a forward chemical genetics screen designed to identify small molecule inhibitors of endothelial morphogenesis. This screen resulted in the identification of structurally-related small molecules that inhibited endothelial cell proliferation, migration, the ability to form tubule-like structures in matrigel, as well as neo- angiogenesis visualized using a dorsal skin fold vascular window chamber. Biochemical analysis revealed that the novel small molecules inhibited ENOX1, a plasma membrane- associated enzyme that exhibits protein disulfide-thiol interchange activity. While ENOX activity is important for cellular proliferation, the molecular mechanisms are not well understood. shRNA-mediated inhibition of ENOX activity in HUVECs inhibited endothelial cell migration and formation of tubule-like structures in matrigel, reproducing the effects of the small molecule inhibitors. Small molecule inhibition of ENOX1 was associated with a significant increase in endothelial cell apoptosis induced by ionizing radiation. Colony formation assays demonstrated that these small molecules increased the radiation sensitivity of endothelial cells. In contrast, the radiation sensitivity of tumor epithelial cells was unaffected by the small molecules. Administration of a small molecule ENOX1 inhibitor prior to fractionated X-irradiation produced a statistically significant decrease in the number and density of CD34 expressing Lewis Lung Carcinoma (LLC) tumor-associated microvasculature. Use of LLC and human HT29 colon carcinoma tumor models demonstrated that the small molecule ENOX1 inhibitors coupled with fractionated X-irradiation produced a statistically significant increase in tumor growth delay compared to irradiation alone. No evidence of acute toxicity was observed over a 30 day interval when mice received a bolus injection of 120 mg/kg. These preliminary data support the hypothesis that ENOX1 represents a rationale molecular target for increasing the ability of ionizing radiation to control tumor growth. The short term goal of this application is to valid this hypothesis. The long term goal is to develop these small molecule inhibitors into a radiation sensitizer that exhibits clinical efficacy.
PUBLIC HEALTH RELEVANCE:
A forward chemical genetics screen identifies small molecule inhibitors of endothelial morphogenesis. Biochemical analysis revealed that these novel small molecules inhibited the enzyme ENOX1, increased the radiation sensitivity of endothelial cells, increased radiation- mediated suppression of tumor-associated vasculature, thereby suppressing tumor growth. These preliminary data support the hypothesis that ENOX1 represents a rationale molecular target for increasing the ability of ionizing radiation to control tumor growth.
描述(由申请人提供):
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
MICHAEL L. FREEMAN其他文献
MICHAEL L. FREEMAN的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('MICHAEL L. FREEMAN', 18)}}的其他基金
The Thromboxane-Prostanoid Receptor in Radiation-Induced Pulmonary Fibrosis
辐射诱发肺纤维化中的血栓素-前列腺素受体
- 批准号:
10734570 - 财政年份:2023
- 资助金额:
$ 1.56万 - 项目类别:
Targeting DNA damage response pathways for the treatment of advanced lung cancer
靶向 DNA 损伤反应途径治疗晚期肺癌
- 批准号:
8776675 - 财政年份:2014
- 资助金额:
$ 1.56万 - 项目类别:
Nrf2 and Radiation-induced pulmonary fibrosis.
Nrf2 和辐射诱导的肺纤维化。
- 批准号:
8791125 - 财政年份:2013
- 资助金额:
$ 1.56万 - 项目类别:
Nrf2 and Radiation-induced pulmonary fibrosis.
Nrf2 和辐射诱导的肺纤维化。
- 批准号:
8606883 - 财政年份:2013
- 资助金额:
$ 1.56万 - 项目类别:
Nrf2 and Radiation-induced pulmonary fibrosis.
Nrf2 和辐射诱导的肺纤维化。
- 批准号:
8664750 - 财政年份:2013
- 资助金额:
$ 1.56万 - 项目类别:
Nrf2 and Radiation-induced pulmonary fibrosis.
Nrf2 和辐射诱导的肺纤维化。
- 批准号:
8442128 - 财政年份:2013
- 资助金额:
$ 1.56万 - 项目类别:
Development of Small Molecule Radiation Sensitizers
小分子放射增敏剂的开发
- 批准号:
8196782 - 财政年份:2009
- 资助金额:
$ 1.56万 - 项目类别:
Development of Small Molecule Radiation Sensitizers
小分子放射增敏剂的开发
- 批准号:
8002086 - 财政年份:2009
- 资助金额:
$ 1.56万 - 项目类别:
Development of Small Molecule Radiation Sensitizers
小分子放射增敏剂的开发
- 批准号:
7787394 - 财政年份:2009
- 资助金额:
$ 1.56万 - 项目类别:
Development of Small Molecule Radiation Sensitizers
小分子放射增敏剂的开发
- 批准号:
8586851 - 财政年份:2009
- 资助金额:
$ 1.56万 - 项目类别:
相似海外基金
Novel Therapeutic Strategies through Pericyte Modulation and Apoptosis Prevention in Acute Encephalopathy
通过周细胞调节和细胞凋亡预防治疗急性脑病的新治疗策略
- 批准号:
22K09194 - 财政年份:2022
- 资助金额:
$ 1.56万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Characterizing the role of MARCH5 in apoptosis regulation in acute myeloid leukemia
表征 MARCH5 在急性髓系白血病细胞凋亡调节中的作用
- 批准号:
10284146 - 财政年份:2021
- 资助金额:
$ 1.56万 - 项目类别:
Characterizing the role of MARCH5 in apoptosis regulation in acute myeloid leukemia
表征 MARCH5 在急性髓系白血病细胞凋亡调节中的作用
- 批准号:
10473763 - 财政年份:2021
- 资助金额:
$ 1.56万 - 项目类别:
Pharmacologically-directed termination of anti-apoptosis to overcome drug resistance in acute leukemia.
药理学指导终止抗凋亡以克服急性白血病的耐药性。
- 批准号:
21K07239 - 财政年份:2021
- 资助金额:
$ 1.56万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
L-asparaginase-induced mechanisms of acute lymphoblastic leukemia (aLL) cell apoptosis
L-天冬酰胺酶诱导急性淋巴细胞白血病(aLL)细胞凋亡的机制
- 批准号:
433194 - 财政年份:2020
- 资助金额:
$ 1.56万 - 项目类别:
Operating Grants
Designing durable apoptosis-targeting therapies for acute myeloid leukemia
设计针对急性髓系白血病的持久凋亡靶向疗法
- 批准号:
9267819 - 财政年份:2016
- 资助金额:
$ 1.56万 - 项目类别:
Apoptosis Signaling in Vocal Fold Epithelium in Response to Acute Phonotrauma
声带上皮细胞凋亡信号对急性声损伤的反应
- 批准号:
9079268 - 财政年份:2015
- 资助金额:
$ 1.56万 - 项目类别:
Protecting liver sinusoidal endothelial cells suppresses apoptosis in acute liver damage
保护肝窦内皮细胞抑制急性肝损伤时的细胞凋亡
- 批准号:
15K19870 - 财政年份:2015
- 资助金额:
$ 1.56万 - 项目类别:
Grant-in-Aid for Young Scientists (B)
Apoptosis Signaling in Vocal Fold Epithelium in Response to Acute Phonotrauma
声带上皮细胞凋亡信号对急性声损伤的反应
- 批准号:
8981151 - 财政年份:2015
- 资助金额:
$ 1.56万 - 项目类别:
Defining the role of beta2-integrin signaling for regulating cell survival, proliferation and apoptosis in acute myeloid leukemia
定义β2-整合素信号传导在调节急性髓系白血病细胞存活、增殖和凋亡中的作用
- 批准号:
250670454 - 财政年份:2014
- 资助金额:
$ 1.56万 - 项目类别:
Research Grants